Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Mylan Specialty L.P. Stories

2014-03-01 12:20:28

Two poster presentations will highlight initial findings from The Anaphylaxis Risk Assessment (TARA) study, one of the largest U.S. managed care retrospective database reviews to date PITTSBURGH, March 1, 2014 /PRNewswire/ -- Mylan Specialty will present initial data from The Anaphylaxis Risk Assessment (TARA) study at the 2014 Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) held in San Diego, Calif., Feb. 28 - March 4. TARA aims to uncover factors associated...

2013-12-18 08:29:04

Thousands of Hands Raised Demonstrate Nationwide Call for Increased Awareness of Life-Threatening Allergies PITTSBURGH, Dec. 18, 2013 /PRNewswire/ -- Today, Emmy(®)-award winning actress Julie Bowen joined Mylan Specialty to announce the four winning school districts of the Raise Your Hand for Anaphylaxis Awareness(TM) competition. As part of the larger Get Schooled in Anaphylaxis(TM) initiative, the competition called for local communities to educate others in the school environment to...

2013-09-09 08:26:43

Get Schooled in Anaphylaxis(TM) Characters 'Ana and Phyl Axis' Teach Children About Life-Threatening Allergic Reactions and the Importance of Anaphylaxis Awareness and Preparedness BASKING RIDGE, N.J., Sept. 9, 2013 /PRNewswire/ -- The Mylan Specialty L.P. initiative Get Schooled in Anaphylaxis(TM) today launched a new tool, a children's e-book narrated by Emmy(®)-award winning actress Julie Bowen, to help raise awareness of and preparedness for life-threatening allergic reactions,...

2013-08-14 08:29:14

This Back-to-School Season, Mylan Specialty L.P. Encourages People to be Better Prepared for a Life-Threatening Allergic Reaction BASKING RIDGE, N.J., Aug. 14, 2013 /PRNewswire/ -- Mylan Specialty L.P., the fully integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL), today announced it is continuing the EpiPen4Schools(TM) program. In its first year, more than 20,000 schools across all 50 states participated in the program that offers four free EpiPen or EpiPen Jr(®)...

2013-06-18 08:30:30

Inspired by the millions of people who have made EpiPen® (epinephrine) Auto-Injector the No. 1 prescribed epinephrine auto-injector for 25 years, Mylan Specialty's anniversary campaign educates, engages and gives back to the allergy community BASKING RIDGE, N.J., June 18, 2013 /PRNewswire/ -- Pro football player and 2012 most valuable player (MVP) Adrian Peterson and professional family expert Jo Frost have potentially life-threatening (severe) allergies and are partnering with...

2013-05-29 12:26:42

In support of National Asthma and Allergy Awareness Month, Mylan goes to bat to help baseball fans with peanut allergies enjoy one of America's favorite pastimes BASKING RIDGE, N.J., May 29, 2013 /PRNewswire/ -- Mylan Specialty L.P., the fully integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), today announced it is partnering with an all-star roster of baseball teams to host Allergy Awareness games at select stadiums across the country. Mylan Specialty, the...

2013-05-21 12:27:10

Total of $60,000 Will Be Awarded to School Districts In Educational Grants Recommended for Anaphylaxis Education BASKING RIDGE, N.J., May 21, 2013 /PRNewswire/ -- As part of the national Get Schooled in Anaphylaxis(TM) initiative, Emmy(®)-award winning actress Julie Bowen today kicked off Raise Your Hand for Anaphylaxis Awareness(TM), a community-driven competition designed to bring attention to the issue of life-threatening allergic reactions, or anaphylaxis. Sponsored by Mylan...

2013-05-10 12:24:30

More Than 65 Family-Friendly Walks Raise Food Allergy Awareness BASKING RIDGE, N.J., May 10, 2013 /PRNewswire/ -- In recognition of Food Allergy Awareness Week, Mylan Specialty L.P., the fully integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL), today announced their participation as the national presenting sponsor of the Food Allergy Research & Education (FARE) Walk for Food Allergy. With an estimated one in 13 children in the U.S. living with a food...

2013-04-25 08:35:45

Marketer of EpiPen® Auto-Injector, the No. 1 prescribed epinephrine auto-injector, announces additional efforts to increase anaphylaxis awareness, preparedness and access to treatment for those affected by life-threatening allergies BASKING RIDGE, N.J., April 25, 2013 /PRNewswire/ -- Mylan Specialty L.P., the fully integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), is celebrating the 25(th) anniversary of the U.S. Food and Drug Administration's (FDA)...

2013-02-20 12:26:18

BASKING RIDGE, N.J., Feb. 20, 2013 /PRNewswire/ -- Since Mylan Specialty L.P., the fully-integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), launched the EpiPen4Schools(TM) program in August 2012, thousands of schools across the country have elected to participate and redeem free EpiPen(®) or EpiPen Jr(®) (epinephrine) Auto-Injectors. The program was created to help schools have improved access to epinephrine in the event a person experiences a life-threatening...